Abstract

Oligodendrocyte (OL) injury and subsequent loss is a pathologic hallmark of multiple sclerosis (MS). Stress granules (SGs) are membrane-less organelles containing mRNAs stalled in translation and considered as participants of the cellular response to stress. Here we show SGs in OLs in active and inactive areas of MS lesions as well as in normal-appearing white matter. In cultures of primary human adult brain derived OLs, metabolic stress conditions induce transient SG formation in these cells. Combining pro-inflammatory cytokines, which alone do not induce SG formation, with metabolic stress results in persistence of SGs. Unlike sodium arsenite, metabolic stress induced SG formation is not blocked by the integrated stress response inhibitor. Glycolytic inhibition also induces persistent SGs indicating the dependence of SG formation and disassembly on the energetic glycolytic properties of human OLs. We conclude that SG persistence in OLs in MS reflects their response to a combination of metabolic stress and pro-inflammatory conditions.

Oligodendrocyte (OL) injury and loss is a pathologic hallmark of multiple sclerosis. Here, the authors show the presence of stress granules in OLs in multiple sclerosis lesions, and their in vitro studies in human OLs indicate that stress granules formation is a response to a combination of metabolic stress and pro-inflammatory conditions.

Details

Title
Regulation of stress granule formation in human oligodendrocytes
Author
Pernin, Florian 1 ; Cui, Qiao-Ling 1 ; Mohammadnia, Abdulshakour 1 ; Fernandes, Milton G. F. 1   VIAFID ORCID Logo  ; Hall, Jeffery A. 2 ; Srour, Myriam 3 ; Dudley, Roy W. R. 4 ; Zandee, Stephanie E. J. 5 ; Klement, Wendy 5 ; Prat, Alexandre 5   VIAFID ORCID Logo  ; Salapa, Hannah E. 6   VIAFID ORCID Logo  ; Levin, Michael C. 6   VIAFID ORCID Logo  ; Moore, G. R. Wayne 1 ; Kennedy, Timothy E. 1   VIAFID ORCID Logo  ; Vande Velde, Christine 5   VIAFID ORCID Logo  ; Antel, Jack P. 1   VIAFID ORCID Logo 

 McGill University, Neuroimmunology Unit, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 McGill University Health Centre, Department of Neurosurgery, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811) 
 Montreal Children’s Hospital, Division of Pediatric Neurology, Montreal, Canada (GRID:grid.416084.f) (ISNI:0000 0001 0350 814X) 
 Montreal Children’s Hospital, Department of Pediatric Neurosurgery, Montreal, Canada (GRID:grid.416084.f) (ISNI:0000 0001 0350 814X) 
 Centre de Recherche Hospitalier de l’Université de Montréal, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357) 
 University of Saskatchewan, Cameco Multiple Sclerosis Neuroscience Research Center, Saskatoon, Canada (GRID:grid.25152.31) (ISNI:0000 0001 2154 235X) 
Pages
1524
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2928443638
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.